Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics
GET POWR RATINGS... FREE!
ENZ Stock Summary
- ENZ's went public 36.94 years ago, making it older than 93.49% of listed US stocks we're tracking.
- Over the past twelve months, ENZ has reported earnings growth of -334.14%, putting it ahead of only 4.96% of US stocks in our set.
- Revenue growth over the past 12 months for ENZO BIOCHEM INC comes in at -9.05%, a number that bests just 14.23% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to ENZO BIOCHEM INC are SWBI, CYAN, ANGI, DGLY, and TAYD.
- ENZ's SEC filings can be seen here. And to visit ENZO BIOCHEM INC's official web site, go to www.enzo.com.
ENZ Valuation Summary
- ENZ's EV/EBIT ratio is -5.1; this is 159.3% lower than that of the median Healthcare stock.
- Over the past 243 months, ENZ's price/sales ratio has gone down 7.5.
Below are key valuation metrics over time for ENZ.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ENZ | 2022-11-25 | 0.9 | 1.8 | -5.2 | -5.1 |
| ENZ | 2022-11-23 | 0.9 | 1.8 | -5.3 | -5.2 |
| ENZ | 2022-11-22 | 0.9 | 1.8 | -5.3 | -5.2 |
| ENZ | 2022-11-21 | 0.9 | 1.8 | -5.3 | -5.2 |
| ENZ | 2022-11-18 | 0.9 | 1.8 | -5.3 | -5.2 |
| ENZ | 2022-11-17 | 0.9 | 1.8 | -5.5 | -5.4 |
ENZ Growth Metrics
- The 4 year net income to common stockholders growth rate now stands at -197.11%.
- Its 4 year cash and equivalents growth rate is now at -12.85%.
- The year over year cash and equivalents growth rate now stands at 106.31%.
The table below shows ENZ's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-06-30 | 107.071 | -16.59 | -18.261 |
| 2022-03-31 | 111.6 | -7.412 | -6.56 |
| 2021-12-31 | 118.175 | -4.258 | 0.3 |
| 2021-09-30 | 115.595 | -4.448 | 5.257 |
| 2021-06-30 | 117.731 | 0.387 | 7.875 |
| 2021-03-31 | 112.445 | -4.782 | 1.282 |
ENZ's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ENZ has a Quality Grade of B, ranking ahead of 78.47% of graded US stocks.
- ENZ's asset turnover comes in at 1.04 -- ranking 20th of 81 Healthcare stocks.
- LFMD, RHE, and AHCO are the stocks whose asset turnover ratios are most correlated with ENZ.
The table below shows ENZ's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-07-31 | 1.040 | 0.455 | 0.105 |
| 2021-04-30 | 0.996 | 0.459 | 0.019 |
| 2021-01-31 | 0.850 | 0.414 | -0.189 |
| 2020-10-31 | 0.736 | 0.355 | -0.371 |
| 2020-07-31 | 0.646 | 0.313 | -0.499 |
| 2020-04-30 | 0.666 | 0.288 | -0.621 |
ENZ Stock Price Chart Interactive Chart >
ENZ Price/Volume Stats
| Current price | $1.95 | 52-week high | $3.70 |
| Prev. close | $1.99 | 52-week low | $1.90 |
| Day low | $1.95 | Volume | 33,678 |
| Day high | $2.02 | Avg. volume | 67,462 |
| 50-day MA | $2.16 | Dividend yield | N/A |
| 200-day MA | $2.49 | Market Cap | 95.00M |
Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio
Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.
Latest ENZ News From Around the Web
Below are the latest news stories about ENZO BIOCHEM INC that investors may wish to consider to help them evaluate ENZ as an investment opportunity.
As Enzo Biochem, Inc. (NYSE:ENZ) drops to US$100m market cap, insiders might rethink their US$3.1m stock purchase earlier this yearThe recent 13% drop in Enzo Biochem, Inc.'s ( NYSE:ENZ ) stock could come as a blow to insiders who purchased US$3.1m... |
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ MeetingNEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that its Annual Shareholders’ Meeting will be held on January 31, 2023. Shareholders must submit proposals and/or director nominations in connection with meeting no later than November 18, 2022 to be considered timely. About Enzo Biochem Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical labor |
Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NWNORTHLAKE, Texas, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ: FARM) (the “Company”), today announced it has entered into a cooperation agreement (the “Cooperation Agreement”) with JCP Investment Management, LLC (collectively with its affiliates, “JCP”) and 22NW, LP (collectively with its affiliates, “22NW”), which together own approximately 15.7% of the Company’s outstanding common stock. Under the Cooperation Agreement, the Company has agreed to promptly appoint Bradley L. Radof |
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO- David Bench resigning to pursue a new career opportunity -NEW YORK, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointment of Patricia Eckert, CPA, as interim Chief Financial Officer (CFO). Ms. Eckert’s appointment follows the resignation of David Bench, who is departing the Company effective November 14, 2022 to pursue a new opportunity. “While bittersweet in light of David’ |
The past five years for Enzo Biochem (NYSE:ENZ) investors has not been profitableLong term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic... |
ENZ Price Returns
| 1-mo | -10.14% |
| 3-mo | -18.07% |
| 6-mo | -20.41% |
| 1-year | -42.31% |
| 3-year | -26.42% |
| 5-year | -79.39% |
| YTD | -39.25% |
| 2021 | 27.38% |
| 2020 | -4.18% |
| 2019 | -5.40% |
| 2018 | -65.89% |
| 2017 | 17.44% |
Continue Researching ENZ
Want to do more research on Enzo Biochem Inc's stock and its price? Try the links below:Enzo Biochem Inc (ENZ) Stock Price | Nasdaq
Enzo Biochem Inc (ENZ) Stock Quote, History and News - Yahoo Finance
Enzo Biochem Inc (ENZ) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...